Apeloa Pharmaceutical

Apeloa Pharmaceutical

World Rank (Jan-05-2024)
4,966
Market Cap (Jan-05-2024)
2.494 Billion USD
World Rank (Jul-30-2023)
4,464
Market Cap (Jul-30-2023)
2.905 Billion USD
World Rank (Jan-07-2022)
2,851
Market Cap (Jan-07-2022)
5.941 Billion USD
World Rank (Jan-01-2021)
3,378
Market Cap (Jan-01-2021)
4.200 Billion USD
Company Rank in Country in 2023
Rank in China in July-2023 is 834
Headquarters Country
China
Market Cap (Mar-08-2026)
3.07
Employee Count
5,719
Employee Count as of Date
As on 2019
World Region
Asia
World Subregion
Eastern Asia
Annual Revenue in USD
1,404 Million USD
Annual Net Income in USD
150 Million USD
Annual Results for Period Ending
Dec-2021 ending year
Total Assets in USD
1,438 Million USD
Total Liabilities in USD
644 Million USD
Total Equity in USD
794 Million USD
Balance Sheet for Period Ending
Dec-2021 ending year
Business Sector
Healthcare
Pharmaceutical
HealthCare Products
Company Website
APELOA PHARMACEUTICAL
Yahoo
Yahoo @ Shenzhen
Company Profile
Apeloa Pharmaceutical is a engaged in the research and development, production and sales of pharmaceutical products company. The products are mainly concentrated in cardio cerebrovascular, anti infection, anti tumor and other treatment areas. The headquarters is in China.
Facts About Company
Apeloa Pharmaceutical company annual revenue was 10.5 billion CNY and annual net income was 989 million CNY for year ending Dec-2022.
Stock Exchange
Shenzhen
Company SubCategory
Top Healthcare Companies in China

Share